Truist Securities Maintains Hold on Amrize, Lowers Price Target to $35
Truist Securities analyst Keith Hughes maintains Amrize (NYSE:AMRZ) with a Hold and lowers the price target from $48 to $35.
What This Story Means
Claude is explaining the story in plain words…
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site: Benzinga